ペプチド合成市場 – 2029年までの世界予測

Report Overview

The global peptide synthesis market is projected to surpass USD 1.41 billion in 2029 from USD 0.81 billion in 2024, with a significant CAGR of 11.7%.

世界のペプチド合成市場は、2024年の8億1,000万米ドルから2029年には14億1,000万米ドルを超え、11.7%という大幅なCAGRで成長すると予測されています。

The peptide synthesis market is driven by several factors such as advancements in technology, increasing research in drug discovery, and the growing demand for personalized medicine. Additionally, the rising prevalence of chronic diseases such as cancer and diabetes is fueling demand for therapeutic peptides in targeted therapies further propelling the growth of the market.

ペプチド合成市場は、技術の進歩、創薬研究の増加、個別化医療への需要の高まりなど、いくつかの要因によって推進されています。さらに、がんや糖尿病などの慢性疾患の有病率の上昇により、標的療法における治療用ペプチドの需要が高まり、市場の成長をさらに推進しています。

“Resins and Amino acids accounted for the dominant share in the reagents market”

Based on offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Resins form the foundation of solid-phase peptide synthesis (SPPS), serving as a stable platform for the stepwise construction of peptide chains. Advancements in resins such as preloaded resins and specialized linkers are likely to impact positively on the market.

“Peptide synthesis services dominated the market”

The services segment is further segmented into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. Peptide synthesis services dominated the market due to their ability to meet the increasing demand for custom and complex peptides required in drug discovery, therapeutic development, and research applications. Additionally, the rise of personalized medicine and peptide-based vaccines has increased the demand for custom synthesis driving the segmental growth.

“Therapeutics segment dominated the application segment in 2023”

Applications segment is divided into Therapeutics, Diagnostics and Research & Development. Therapeutics by Indications (Cancer, Diabetes, Obesity, Autoimmune Disease and Other Disease Indication), Therapeutics by Molecules (Peptide-Based Vaccines, Peptide-Drug Conjugates (PDCs), Peptide Inhibitors and Other Molecules). Advancements in peptide synthesis technologies, such as solid-phase peptide synthesis (SPPS) and recombinant DNA methods, has enabled the efficient production of high-purity, cost-effective peptides for vaccine development. The growing focus on personalized immunotherapies and increased investment in peptide-based vaccine research further reinforce their leading position in the market.

“North America: the largest share of the peptide synthesis market”

The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the peptide synthesis market in 2023 and is estimated to continue dominance during the forecast period. US leads the North American market, driven by the strong presence of key players like Thermo Fisher Scientific and CEM Corporation, with substantial funding for biomedical research and innovation in peptide-based therapeutics. Europe holds a significant share of the market, with countries like Germany, and UK being major contributors. This dominance attributed to strong R&D activities, collaborations between academic institutions and industry, and a growing focus on personalized medicine and peptide-based drugs.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the peptide synthesis market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Tier 1- 45%, Tier 2- 35%, Tier 3- 20%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Bachem Holding AG (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), GenScript (China), and CEM Corporation (US) are some of the major players operating in the peptide synthesis market.

Research Coverage:

This research report categorizes the peptide synthesis market offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Services (Peptide Library Synthesis, Peptide Synthesis, Peptide Purification Services and Peptide Analysis Services), Technique (Chemical (Solid Phase Peptide Synthesis, Solution Phase peptide synthesis and Other Chemical Methods and Biological (Recombinant DNA Technology and Enzymes), Applications (Therapeutics, Diagnostics and Research & Development), Therapeutics by Indications (Cancer, Diabetes, Obesity, Autoimmune Disease and Other Disease Indication), Therapeutics by Molecules (Peptide-Based Vaccines, Peptide-Drug Conjugates (PDCs), Peptide Inhibitors and Other Molecules), End User (Pharmaceutical and biotechnology companies, CDMOs & CROs, Academic & Research Institutes, Medical Device Companies and Hospitals and Diagnostic Centers). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the peptide synthesis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the peptide synthesis market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the peptide synthesis and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (advancements in peptide therapeutics, technological advancements, growing use of peptides in diagnostics and research), restraints (Regulatory Hurdles, High cost of peptide synthesis and instruments), opportunities (Adoption of personalized medicine, Rise in strategic collaborations and partnerships) and Challenges (Addressing Immunogenicity, Environmental Concerns) influencing the growth of the market.

• Product/Service Development/Innovation: Detailed insights on upcoming technologies in peptide synthesis manufacturing, research and development activities, and new product/service launches in the peptide synthesis market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the peptide synthesis market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players Thermo Fisher Scientific, Inc. (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Inc. and Merck KGaA (Germany), among others.

Table of Contents

1               INTRODUCTION              54

1.1           STUDY OBJECTIVES       54

1.2           MARKET DEFINITION   54

1.3           STUDY SCOPE   55

1.3.1        MARKETS COVERED       55

1.3.2        REGIONAL SCOPE            56

1.3.3        INCLUSIONS AND EXCLUSIONS 56

1.3.4        YEARS CONSIDERED      57

1.4           CURRENCY CONSIDERED            57

1.5           STAKEHOLDERS               57

1.6           SUMMARY OF CHANGES               58

2               RESEARCH METHODOLOGY       59

2.1           RESEARCH DATA              59

2.1.1        SECONDARY RESEARCH                60

2.1.2        PRIMARY RESEARCH       61

2.2           MARKET SIZE ESTIMATION METHODOLOGY     62

2.2.1        GLOBAL MARKET ESTIMATION 62

2.2.2        INSIGHTS FROM PRIMARY EXPERTS        65

2.2.3        SEGMENTAL MARKET ESTIMATION (TOP-DOWN APPROACH)       65

2.3           GROWTH RATE PROJECTIONS  67

2.4           DATA TRIANGULATION                69

2.5           RESEARCH ASSUMPTIONS           70

2.6           RESEARCH LIMITATIONS             71

2.7           RISK ANALYSIS  71

3               EXECUTIVE SUMMARY  72

4               PREMIUM INSIGHTS       78

4.1           PEPTIDE SYNTHESIS MARKET OVERVIEW            78

4.2           NORTH AMERICA: PEPTIDE SYNTHESIS MARKET,

BY PRODUCT TYPE AND COUNTRY, 2023              79

4.3           PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024 VS. 2029        79

4.4           PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              80

5               MARKET OVERVIEW       81

5.1           INTRODUCTION              81

5.2           MARKET DYNAMICS       81

5.2.1        DRIVERS               82

5.2.1.1    Advancements in peptide therapeutics             82

5.2.1.2    Innovations in peptide synthesis instruments  83

5.2.1.3    Growing use of peptides in diagnostics and research     83

5.2.2        RESTRAINTS      84

5.2.2.1    Regulatory hurdles               84

5.2.2.2    High cost of peptide synthesis and instruments               84

5.2.3        OPPORTUNITIES              85

5.2.3.1    Adoption of personalized medicine   85

5.2.3.2    Strategic collaborations and partnerships         85

5.2.4        CHALLENGES    86

5.2.4.1    Immunogenicity issues        86

5.2.4.2    Environmental concerns      86

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            87

5.4           PRICING ANALYSIS          87

5.4.1        AVERAGE SELLING PRICE TREND, BY KEY PLAYER                 88

5.4.2        AVERAGE SELLING PRICE TREND, BY REGION   91

5.5           SUPPLY CHAIN ANALYSIS             93

5.6           VALUE CHAIN ANALYSIS               94

5.7           ECOSYSTEM ANALYSIS  97

5.7.1        PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS           97

5.7.2        PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS                 98

5.7.3        PEPTIDE SYNTHESIS MARKET: END USERS          98

5.7.4        PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES                 99

5.8           INVESTMENT AND FUNDING SCENARIO               99

5.9           TECHNOLOGY ANALYSIS             100

5.9.1        KEY TECHNOLOGIES     100

5.9.1.1    Solid-phase peptide synthesis (SPPS)               100

5.9.1.2    Liquid-phase peptide synthesis (LPPS)           100

5.9.1.3    Enzymatic peptide synthesis               101

5.9.1.4    Continuous-flow peptide synthesis   101

5.9.2        COMPLEMENTARY TECHNOLOGIES       101

5.9.2.1    Labeling and tracking technologies   101

5.9.2.2    Purification techniques       102

5.9.3        ADJACENT TECHNOLOGIES       102

5.9.3.1    Cell-free protein synthesis  102

5.9.3.2    Protein design and engineering          102

5.10         PATENT ANALYSIS          103

5.11         TRADE ANALYSIS             105

5.11.1      TRADE DATA FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS)                 105

5.11.1.1  Import data for HS code 902720        105

5.11.1.2  Export data for HS CODE 902720    106

5.11.2      TRADE DATA FOR HS CODE 841933 (LYOPHILISATION APPARATUS,

FREEZE DRYING UNITS AND SPRAY DRYERS)     106

5.11.2.1  Import data for HS code 841993        106

5.11.2.2  Export data for HS code 841933         107

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        107

5.13         REGULATORY LANDSCAPE         108

5.13.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             109

5.13.2      REGULATORY FRAMEWORK       112

5.13.2.1  North America      112

5.13.2.1.1                US           112

5.13.2.1.2                Canada   112

5.13.2.2  Europe   112

5.13.2.2.1                Germany                 112

5.13.2.2.2                UK          112

5.13.2.2.3                France    112

5.13.2.3  Asia Pacific            113

5.13.2.3.1                Japan      113

5.13.2.3.2                China      113

5.13.2.4  Latin America       113

5.13.2.4.1                Brazil      113

5.13.2.5  Middle East & Africa            113

5.13.2.5.1                GCC Countries     113

5.13.2.5.2                South Africa           113

5.14         PORTER’S FIVE FORCES ANALYSIS           114

5.14.1      BARGAINING POWER OF SUPPLIERS       115

5.14.2      BARGAINING POWER OF BUYERS             115

5.14.3      THREAT OF NEW ENTRANTS      115

5.14.4      THREAT OF SUBSTITUTES          115

5.14.5      INTENSITY OF COMPETITIVE RIVALRY 116

5.15         KEY STAKEHOLDERS AND BUYING CRITERIA     116

5.15.1      KEY STAKEHOLDERS IN BUYING PROCESS           116

5.15.2      BUYING CRITERIA           117

5.16         IMPACT OF AI/GENERATIVE AI ON PEPTIDE SYNTHESIS MARKET               119

5.16.1      INTRODUCTION              119

5.16.2      IMPACT OF AI ON PEPTIDE SYNTHESIS ECOSYSTEM                 120

5.16.3      FUTURE OF GENERATIVE AI IN PEPTIDE SYNTHESIS ECOSYSTEM       121

6               PEPTIDE SYNTHESIS MARKET, BY OFFERING     122

6.1           INTRODUCTION              123

6.2           PRODUCTS         123

6.2.1        INCREASING ADOPTION OF SOLID AND LIQUID-PHASE PEPTIDE SYNTHESIS TO STIMULATE GROWTH 123

6.3           SERVICES             127

6.3.1        GROWING ADVANCEMENTS IN PEPTIDE DESIGN AND SYNTHESIS OPTIMIZATION TO FUEL MARKET  127

7               PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE                 130

7.1           INTRODUCTION              131

7.2           CONSUMABLES 131

7.2.1        REAGENTS          135

7.2.1.1    Resins     138

7.2.1.1.1 Growing demand for therapeutic peptides to boost market                 138

7.2.1.2    Amino acids           141

7.2.1.2.1 Increasing advancements in synthetic amino acid modifications to aid growth         141

7.2.1.3    Coupling reagents                 144

7.2.1.3.1 Rising adoption of high-throughput peptide synthesis to expedite growth    144

7.2.1.4    Dyes & fluorescent labeling reagents                 147

7.2.1.4.1 Increasing demand for high-resolution, sensitive imaging technologies to promote growth         147

7.2.1.5    Deprotection reagents         150

7.2.1.5.1 Rising complexity of modified peptides and cyclic structures to facilitate growth    150

7.2.1.6    Cleavage reagents 153

7.2.1.6.1 Increasing use of complex peptides to sustain growth    153

7.2.1.7    Other reagents      156

7.2.2        OTHER CONSUMABLES 159

7.3           INSTRUMENTS 162

7.3.1        PEPTIDE SYNTHESIZERS              165

7.3.1.1    Automated peptide synthesizers        169

7.3.1.1.1 Increasing launches of automated peptide synthesizers to promote growth    169

7.3.1.2    Manual peptide synthesizers               172

7.3.1.2.1 Growing use of peptide synthesizers for early-stage drug discovery and research to fuel market                172

7.3.2        CHROMATOGRAPHY SYSTEMS 175

7.3.2.1    Increasing shift toward high-throughput and industrial-scale peptide production to amplify growth               175

7.3.3        LYOPHILIZERS  178

7.3.3.1    Rising influence of contract manufacturing organizations to encourage growth 178

7.3.4        OTHER INSTRUMENTS 181

8               PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE                 185

8.1           INTRODUCTION              186

8.2           PEPTIDE SYNTHESIS      186

8.2.1        RISING ADOPTION OF PERSONALIZED MEDICINES AND TARGETED THERAPIES TO INTENSIFY GROWTH              186

8.3           PEPTIDE PURIFICATION SERVICES          190

8.3.1        GROWING EMPHASIS ON HIGH-QUALITY PEPTIDES IN PHARMACEUTICAL DEVELOPMENT AND BIOTECH TO DRIVE MARKET               190

8.4           PEPTIDE LIBRARY SYNTHESIS   193

8.4.1        INCREASING FOCUS ON SYNTHETIC BIOLOGY TO AUGMENT GROWTH      193

8.5           PEPTIDE ANALYSIS SERVICES    196

8.5.1        INCREASING ADVANCEMENTS IN MASS SPECTROMETRY AND CHROMATOGRAPHY TO BOLSTER GROWTH             196

9               PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE 200

9.1           INTRODUCTION              201

9.2           CHEMICAL METHODS   201

9.2.1        SOLID-PHASE PEPTIDE SYNTHESIS         205

9.2.1.1    Increasing use of peptides and peptide derivatives in modern medicines use to encourage growth   205

9.2.2        LIQUID-PHASE PEPTIDE SYNTHESIS       208

9.2.2.1    Growing advancements in purification technologies to boost market    208

9.2.3        OTHER CHEMICAL METHODS   211

9.3           BIOLOGICAL METHODS               215

9.3.1        RECOMBINANT DNA TECHNOLOGY       218

9.3.1.1    Increasing innovations in genetic engineering and synthetic biology to drive market        218

9.3.2        ENZYMATIC SYNTHESIS                222

9.3.2.1    Growing shift toward sustainable and eco-friendly manufacturing to propel market   222

10            PEPTIDE SYNTHESIS MARKET, BY APPLICATION                 225

10.1         INTRODUCTION              226

10.2         THERAPEUTIC APPLICATIONS  226

10.2.1      THERAPEUTIC APPLICATIONS, BY INDICATION                 230

10.2.1.1  Cancer    230

10.2.1.1.1                Rising clinical trials to contribute to growth    230

10.2.1.2  Diabetes 233

10.2.1.2.1                Increasing need for diabetes management to favor growth    233

10.2.1.3  Obesity  236

10.2.1.3.1                Increasing development of next-generation weight management therapies to foster growth            236

10.2.1.4  Autoimmune diseases          239

10.2.1.4.1                Growing prevalence of rheumatoid arthritis, lupus,

and multiple sclerosis to fuel market 239

10.2.1.5  Other diseases      243

10.2.2      THERAPEUTIC APPLICATIONS, BY MOLECULE  246

10.2.2.1  Peptide-based vaccines       246

10.2.2.1.1                Increasing research on infectious diseases and cancer immunotherapy to augment growth  246

10.2.2.2  Peptide-drug conjugates     250

10.2.2.2.1                Growing focus of pharmaceutical companies on drug conjugation to drive market                250

10.2.2.3  Peptide inhibitors 253

10.2.2.3.1                Rising traction for precision medicine to assist growth                 253

10.2.2.4  Other molecules   257

10.3         DIAGNOSTIC APPLICATIONS     260

10.3.1      RISE OF PERSONALIZED MEDICINE AND POINT-OF-CARE TESTING TO ACCELERATE GROWTH          260

10.4         DISCOVERY & DEVELOPMENT APPLICATIONS  264

10.4.1      GROWING ADVANCEMENTS IN COMBINATORIAL CHEMISTRY AND

HIGH-THROUGHPUT PEPTIDE LIBRARIES TO DRIVE MARKET                 264

11            PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER                 268

11.1         INTRODUCTION              269

11.2         PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES       269

11.2.1      INCREASING RESEARCH ON GENOMICS AND MOLECULAR BIOLOGY TO EXPEDITE GROWTH                269

11.3         CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS     273

11.3.1      SHIFT TOWARD CUSTOM AND MODIFIED PEPTIDES TO DRIVE MARKET 273

11.4         ACADEMIC & RESEARCH INSTITUTES    276

11.4.1      INCREASING FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO SUPPORT GROWTH                 276

11.5         MEDICAL DEVICE COMPANIES 280

11.5.1      BOOMING PEPTIDE-BASED DRUG DELIVERIES TO PROMOTE GROWTH      280

11.6         HOSPITALS & DIAGNOSTIC CENTERS    283

11.6.1      RISING DEMAND FOR PEPTIDE-BASED DIAGNOSTICS TO FAVOR GROWTH      283

12            PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER                 287

12.1         INTRODUCTION              288

12.2         PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES       288

12.2.1      INCREASING FOCUS ON PEPTIDE-BASED THERAPEUTICS IN ONCOLOGY AND METABOLIC DISORDERS TO INTENSIFY GROWTH               288

12.3         MEDICAL DEVICE COMPANIES 292

12.3.1      NEED TO DETECT INFECTIOUS DISEASES, CANCER, AND METABOLIC DISORDERS TO AID GROWTH                292

12.4         HOSPITALS & DIAGNOSTIC CENTERS    295

12.4.1      RISING USE OF PEPTIDE BIOMARKERS TO SUPPORT GROWTH             295

12.5         ACADEMIC & RESEARCH INSTITUTES    299

12.5.1      GROWING FOCUS ON DRUG DESIGN, VACCINE DEVELOPMENT,

AND CANCER RESEARCH TO BOOST MARKET    299

12.6         CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS     302

12.6.1      INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO FACILITATE GROWTH                302

13            PEPTIDE SYNTHESIS MARKET, BY REGION          306

13.1         INTRODUCTION              307

13.2         NORTH AMERICA             307

13.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 308

13.2.2      US           314

13.2.2.1  Well-developed healthcare and research infrastructure to aid growth    314

13.2.3      CANADA               320

13.2.3.1  Increasing government funding for advanced drugs to amplify growth    320

13.3         EUROPE               326

13.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      327

13.3.2      GERMANY           333

13.3.2.1  Germany to hold largest market share in Europe            333

13.3.3      UK          339

13.3.3.1  Increasing peptide synthesis research to contribute to growth                 339

13.3.4      FRANCE                345

13.3.4.1  Favorable government initiatives to augment growth    345

13.3.5      ITALY    351

13.3.5.1  Growing public and private sector investments to propel market                 351

13.3.6      SPAIN    357

13.3.6.1  Rising focus on advanced therapies to expedite growth 357

13.3.7      REST OF EUROPE             363

13.4         ASIA PACIFIC     369

13.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 370

13.4.2      CHINA  377

13.4.2.1  Expanding biopharma sector to advance growth             377

13.4.3      JAPAN   384

13.4.3.1  Growing geriatric population to fuel market    384

13.4.4      INDIA    390

13.4.4.1  Increasing investments and developments in biotechnology to favor growth          390

13.4.5      SOUTH KOREA  395

13.4.5.1  Booming biotechnology sector to amplify growth           395

13.4.6      AUSTRALIA         402

13.4.6.1  Increasing government funding and initiatives to augment growth    402

13.4.7      REST OF ASIA PACIFIC   407

13.5         LATIN AMERICA                413

13.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 414

13.5.2      BRAZIL 420

13.5.2.1  Growing interest in peptide-based drugs to fuel market                 420

13.5.3      MEXICO                426

13.5.3.1  Increasing initiatives for stem cell research and regenerative medicine projects to foster growth    426

13.5.4      REST OF LATIN AMERICA             432

13.6         MIDDLE EAST   438

13.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST                 438

13.6.2      GCC COUNTRIES              445

13.6.2.1  Saudi Arabia          450

13.6.2.1.1                Increasing government-backed investments for infrastructure to aid growth                450

13.6.2.2  UAE        456

13.6.2.2.1                High prevalence of diabetes and cardiovascular diseases to augment growth                456

13.6.2.3  Rest of GCC Countries        462

13.6.3      REST OF MIDDLE EAST 469

13.7         AFRICA 475

13.7.1      INCREASING INVESTMENTS IN PHARMACEUTICAL INFRASTRUCTURE AND LIFE SCIENCE INNOVATIONS TO BOOST MARKET               475

13.7.2      MACROECONOMIC OUTLOOK FOR AFRICA        475

14            COMPETITIVE LANDSCAPE         482

14.1         OVERVIEW          482

14.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025                 482

14.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PEPTIDE SYNTHESIS MARKET    483

14.3         REVENUE ANALYSIS, 2019–2023  484

14.4         MARKET SHARE ANALYSIS, 2023                 485

14.5         COMPANY VALUATION AND FINANCIAL METRICS                 487

14.5.1      COMPANY VALUATION 487

14.5.2      FINANCIAL METRICS      487

14.6         BRAND/PRODUCT COMPARISON             488

14.7         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 489

14.7.1      STARS   489

14.7.2      EMERGING LEADERS     489

14.7.3      PERVASIVE PLAYERS      489

14.7.4      PARTICIPANTS 489

14.7.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         491

14.7.5.1  Company footprint               491

14.7.5.2  Region footprint   492

14.7.5.3  Offering footprint 493

14.7.5.4  Technique footprint             494

14.7.5.5  Application footprint            495

14.8         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        496

14.8.1      PROGRESSIVE COMPANIES         496

14.8.2      RESPONSIVE COMPANIES            496

14.8.3      DYNAMIC COMPANIES  496

14.8.4      STARTING BLOCKS         496

14.8.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 498

14.8.5.1  Detailed list of key startups/SMEs    498

14.8.5.2  Competitive benchmarking of startups/SMEs 499

14.9         COMPETITIVE SCENARIO             500

14.9.1      PRODUCT LAUNCHES   500

14.9.2      DEALS  501

14.9.3      EXPANSIONS     502

15            COMPANY PROFILES      503

15.1         KEY PLAYERS     503

15.1.1      THERMO FISHER SCIENTIFIC INC.            503

15.1.1.1  Business overview 503

15.1.1.2  Products/Services offered   505

15.1.1.3  Recent developments           506

15.1.1.3.1                Product launches  506

15.1.1.4  MnM view              506

15.1.1.4.1                Key strengths        506

15.1.1.4.2                Strategic choices   506

15.1.1.4.3                Weaknesses and competitive threats 506

15.1.2      MERCK KGAA    507

15.1.2.1  Business overview 507

15.1.2.2  Products/Services offered   508

15.1.2.3  MnM view              511

15.1.2.3.1                Key strengths        511

15.1.2.3.2                Strategic choices   511

15.1.2.3.3                Weaknesses and competitive threats 511

15.1.3      AGILENT TECHNOLOGIES, INC.                512

15.1.3.1  Business overview 512

15.1.3.2  Products/Services offered   513

15.1.3.3  MnM view              514

15.1.3.3.1                Key strengths        514

15.1.3.3.2                Strategic choices   514

15.1.3.3.3                Weaknesses and competitive threats 514

15.1.4      GENSCRIPT        515

15.1.4.1  Business overview 515

15.1.4.2  Products/Services offered   516

15.1.4.3  Recent developments           517

15.1.4.3.1                Expansions             517

15.1.4.4  MnM view              517

15.1.4.4.1                Key strengths        517

15.1.4.4.2                Strategic choices   517

15.1.4.4.3                Weaknesses and competitive threats 518

15.1.5      KANEKA CORPORATION               519

15.1.5.1  Business overview 519

15.1.5.2  Products/Services offered   520

15.1.5.3  Recent developments           521

15.1.5.3.1                Expansions             521

15.1.5.4  MnM view              521

15.1.5.4.1                Key strengths        521

15.1.5.4.2                Strategic choices   521

15.1.5.4.3                Weaknesses and competitive threats 521

15.1.6      BACHEM              522

15.1.6.1  Business overview 522

15.1.6.2  Products/Services offered   523

15.1.6.3  Recent developments           524

15.1.6.3.1                Deals      524

15.1.7      SYNGENE INTERNATIONAL LIMITED     525

15.1.7.1  Business overview 525

15.1.7.2  Products/Services offered   526

15.1.8      MESA LABS, INC.               527

15.1.8.1  Business overview 527

15.1.8.2  Products/Services offered   528

15.1.8.3  Recent developments           529

15.1.8.3.1                Product launches  529

15.1.8.3.2                Deals      529

15.1.9      BIOTAGE             530

15.1.9.1  Business overview 530

15.1.9.2  Products/Services offered   532

15.1.10   CEM CORPORATION      533

15.1.10.1                 Business overview 533

15.1.10.2                 Products/Services offered   533

15.1.10.3                 Recent developments           534

15.1.10.3.1             Product launches  534

15.1.10.3.2             Deals      534

15.1.11   DALTON PHARMA SERVICES      535

15.1.11.1                 Business overview 535

15.1.11.2                 Products/Services offered   535

15.1.12   BIO-SYNTHESIS INC.       536

15.1.12.1                 Business overview 536

15.1.12.2                 Products/Services offered   537

15.1.13   CSBIO   538

15.1.13.1                 Business overview 538

15.1.13.2                 Products/Services offered   538

15.1.14   PROTEOGENIX 539

15.1.14.1                 Business overview 539

15.1.14.2                 Products/Services offered   539

15.1.15   INNOVAGEN AB                540

15.1.15.1                 Business overview 540

15.1.15.2                 Products/Services offered   540

15.1.16   BIOSYNTH          541

15.1.16.1                 Business overview 541

15.1.16.2                 Products/Services offered   541

15.1.16.2.1             Deals      542

15.2         OTHER PLAYERS              543

15.2.1      AURIGENE PHARMACEUTICAL SERVICES LTD.  543

15.2.2      CORDENPHARMA            544

15.2.3      JPT PEPTIDE TECHNOLOGIES   545

15.2.4      PUROLITE           546

15.2.5      BIOMATIK           547

15.2.6      CPC SCIENTIFIC INC.     548

15.2.7      ADVANCED CHEMTECH, INC.    549

15.2.8      AMBIOPHARM INC.         550

15.2.9      LUXEMBOURG BIO TECHNOLOGIES       551

15.2.10   AAPPTEC             552

15.2.11   ANYGEN               553

15.2.12   CHEMPEP            554

15.2.13   PROTEOGENIX 555

16            APPENDIX           556

16.1         DISCUSSION GUIDE        556

16.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                560

16.3         CUSTOMIZATION OPTIONS        562

16.4         RELATED REPORTS         562

16.5         AUTHOR DETAILS           563

LIST OF TABLES

TABLE 1                PEPTIDE SYNTHESIS MARKET: INCLUSIONS AND EXCLUSIONS           56

TABLE 2                IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS              68

TABLE 3                PEPTIDE SYNTHESIS MARKET: RISK ANALYSIS                 71

TABLE 4                PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS           82

TABLE 5                AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS,

BY KEY PLAYER, 2022–2024            88

TABLE 6                AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS,

BY REGION, 2022–2024    91

TABLE 7                PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS           97

TABLE 8                PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS        98

TABLE 9                PEPTIDE SYNTHESIS MARKET: END USERS                 98

TABLE 10              PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES 99

TABLE 11              PEPTIDE SYNTHESIS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024       104

TABLE 12              IMPORT VALUE FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS), 2019–2023 (USD)                105

TABLE 13              EXPORT VALUE FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS), 2019–2023 (USD)                106

TABLE 14              IMPORT VALUE FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS, AND SPRAY DRYERS), 2022–2023 (USD)              106

TABLE 15              EXPORT VALUE FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS, AND SPRAY DRYERS), 2022–2023 (USD)              107

TABLE 16              PEPTIDE SYNTHESIS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026                 107

TABLE 17              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  109

TABLE 18              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  109

TABLE 19              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  110

TABLE 20              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  111

TABLE 21              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  111

TABLE 22              PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS           114

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS   117

TABLE 24              KEY BUYING CRITERIA FOR PEPTIDE SYNTHESIS PRODUCTS, BY END USER   118

TABLE 25              PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            123

TABLE 26              PEPTIDE SYNTHESIS PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)          124

TABLE 27              NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               124

TABLE 28              EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               125

TABLE 29              ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               125

TABLE 30              LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               126

TABLE 31              MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   126

TABLE 32              GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               126

TABLE 33              PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          127

TABLE 34              NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               127

TABLE 35              EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               128

TABLE 36              ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               128

TABLE 37              LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               129

TABLE 38              MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   129

TABLE 39              GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               129

TABLE 40              PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)                131

TABLE 41              PEPTIDE CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)            131

TABLE 42              PEPTIDE CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)            132

TABLE 43              NORTH AMERICA: PEPTIDE CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               132

TABLE 44              EUROPE: PEPTIDE CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            133

TABLE 45              ASIA PACIFIC: PEPTIDE CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            133

TABLE 46              LATIN AMERICA: PEPTIDE CONSUMABLES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            134

TABLE 47              MIDDLE EAST: PEPTIDE CONSUMABLES MARKET, BY REGION,

2022–2029 (USD MILLION)            134

TABLE 48              GCC COUNTRIES: PEPTIDE CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               134

TABLE 49              REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)            135

TABLE 50              REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 136

TABLE 51              NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     136

TABLE 52              EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            136

TABLE 53              ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     137

TABLE 54              LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     137

TABLE 55              MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)            137

TABLE 56              GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     138

TABLE 57              RESINS MARKET, BY REGION, 2022–2029 (USD MILLION)            138

TABLE 58              NORTH AMERICA: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     139

TABLE 59              EUROPE: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)       139

TABLE 60              ASIA PACIFIC: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            139

TABLE 61             LATIN AMERICA: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            140

TABLE 62              MIDDLE EAST: RESINS MARKET, BY REGION, 2022–2029 (USD MILLION)            140

TABLE 63              GCC COUNTRIES: RESINS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     140

TABLE 64              AMINO ACIDS MARKET, BY REGION, 2022–2029 (USD MILLION) 141

TABLE 65              NORTH AMERICA: AMINO ACIDS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            142

TABLE 66              EUROPE: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            142

TABLE 67              ASIA PACIFIC: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     142

TABLE 68              LATIN AMERICA: AMINO ACIDS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     143

TABLE 69              MIDDLE EAST: AMINO ACIDS MARKET, BY REGION, 2022–2029 (USD MILLION)          143

TABLE 70              GCC COUNTRIES: AMINO ACIDS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            143

TABLE 71              COUPLING REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)            144

TABLE 72              NORTH AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            145

TABLE 73              EUROPE: COUPLING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            145

TABLE 74              ASIA PACIFIC: COUPLING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            145

TABLE 75              LATIN AMERICA: COUPLING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            146

TABLE 76              MIDDLE EAST: COUPLING REAGENTS MARKET, BY REGION,

2022–2029 (USD MILLION)            146

TABLE 77              GCC COUNTRIES: COUPLING REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            146

TABLE 78              DYES & FLUORESCENT LABELING REAGENTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   147

TABLE 79              NORTH AMERICA: DYES & FLUORESCENT LABELING REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               148

TABLE 80              EUROPE: DYES & FLUORESCENT LABELING REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               148

TABLE 81              ASIA PACIFIC: DYES & FLUORESCENT LABELING REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               149

TABLE 82              LATIN AMERICA: DYES & FLUORESCENT LABELING REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               149

TABLE 83              MIDDLE EAST: DYES & FLUORESCENT LABELING REAGENTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   149

TABLE 84              GCC COUNTRIES: DYES & FLUORESCENT LABELING REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               150

TABLE 85              DEPROTECTION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          151

TABLE 86              NORTH AMERICA: DEPROTECTION REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               151

TABLE 87              EUROPE: DEPROTECTION REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            151

TABLE 88              ASIA PACIFIC: DEPROTECTION REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            152

TABLE 89              LATIN AMERICA: DEPROTECTION REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            152

TABLE 90              MIDDLE EAST: DEPROTECTION REAGENTS MARKET, BY REGION,

2022–2029 (USD MILLION)            152

TABLE 91              GCC COUNTRIES: DEPROTECTION REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            153

TABLE 92              CLEAVAGE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)            153

TABLE 93              NORTH AMERICA: CLEAVAGE REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               154

TABLE 94              EUROPE: CLEAVAGE REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            154

TABLE 95              ASIA PACIFIC: CLEAVAGE REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            154

TABLE 96              LATIN AMERICA: CLEAVAGE REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            155

TABLE 97              MIDDLE EAST: CLEAVAGE REAGENTS MARKET, BY REGION,

2022–2029 (USD MILLION)            155

TABLE 98              GCC COUNTRIES: CLEAVAGE REAGENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            155

TABLE 99              OTHER PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION,

2022–2029 (USD MILLION)            156

TABLE 100            NORTH AMERICA: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               156

TABLE 101            EUROPE: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               157

TABLE 102            ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               157

TABLE 103            LATIN AMERICA: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               158

TABLE 104            MIDDLE EAST: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   158

TABLE 105            GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS REAGENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               158

TABLE 106            OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY REGION, 2022–2029 (USD MILLION)   159

TABLE 107            NORTH AMERICA: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET,

2022–2029 (USD MILLION)            160

TABLE 108            EUROPE: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               160

TABLE 109            ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               161

TABLE 110            LATIN AMERICA: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               161

TABLE 111            MIDDLE EAST: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY REGION, 2022–2029 (USD MILLION)   161

TABLE 112            GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               162

TABLE 113            PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)            162

TABLE 114            PEPTIDE SYNTHESIS INSTRUMENTS MARKET, BY REGION,

2022–2029 (USD MILLION)            163

TABLE 115            NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               163

TABLE 116            EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               163

TABLE 117            ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               164

TABLE 118            LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               164

TABLE 119            MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   164

TABLE 120            GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               165

TABLE 121            PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)            166

TABLE 122            PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)            166

TABLE 123            NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               166

TABLE 124            EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            167

TABLE 125          ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            167

TABLE 126            LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            168

TABLE 127            MIDDLE EAST: PEPTIDE SYNTHESIZERS MARKET, BY REGION,

2022–2029 (USD MILLION)            168

TABLE 128            GCC COUNTRIES: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            168

TABLE 129          AUTOMATED PEPTIDE SYNTHESIZERS MARKET, BY REGION,

2022–2029 (USD MILLION)            169

TABLE 130            NORTH AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               170

TABLE 131            EUROPE: AUTOMATED PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               170

TABLE 132            ASIA PACIFIC: AUTOMATED PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               171

TABLE 133            LATIN AMERICA: AUTOMATED PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               171

TABLE 134            MIDDLE EAST: AUTOMATED PEPTIDE SYNTHESIZERS MARKET,

BY REGION, 2022–2029 (USD MILLION)   171

TABLE 135            GCC COUNTRIES: AUTOMATED PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)             172

TABLE 136            MANUAL PEPTIDE SYNTHESIZERS MARKET, BY REGION,

2022–2029 (USD MILLION)            172

TABLE 137            NORTH AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               173

TABLE 138            EUROPE: MANUAL PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               173

TABLE 139            ASIA PACIFIC: MANUAL PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               174

TABLE 140            LATIN AMERICA: MANUAL PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               174

TABLE 141            MIDDLE EAST: MANUAL PEPTIDE SYNTHESIZERS MARKET,

BY REGION, 2022–2029 (USD MILLION)   174

TABLE 142            GCC COUNTRIES: MANUAL PEPTIDE SYNTHESIZERS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               175

TABLE 143            CHROMATOGRAPHY SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)          176

TABLE 144            NORTH AMERICA: CHROMATOGRAPHY SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               176

TABLE 145            EUROPE: CHROMATOGRAPHY SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               176

TABLE 146            ASIA PACIFIC: CHROMATOGRAPHY SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               177

TABLE 147            LATIN AMERICA: CHROMATOGRAPHY SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               177

TABLE 148            MIDDLE EAST: CHROMATOGRAPHY SYSTEMS MARKET,

BY REGION, 2022–2029 (USD MILLION)   177

TABLE 149            GCC COUNTRIES: CHROMATOGRAPHY SYSTEMS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               178

TABLE 150            LYOPHILIZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 179

TABLE 151            NORTH AMERICA: LYOPHILIZERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            179

TABLE 152          EUROPE: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            179

TABLE 153            ASIA PACIFIC: LYOPHILIZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     180

TABLE 154            LATIN AMERICA: LYOPHILIZERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            180

TABLE 155            MIDDLE EAST: LYOPHILIZERS MARKET, BY REGION, 2022–2029 (USD MILLION)          180

TABLE 156            GCC COUNTRIES: LYOPHILIZERS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            181

TABLE 157            OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   181

TABLE 158            NORTH AMERICA: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               182

TABLE 159            EUROPE: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               182

TABLE 160            ASIA PACIFIC: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               183

TABLE 161            LATIN AMERICA: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               183

TABLE 162            MIDDLE EAST: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY REGION, 2022–2029 (USD MILLION)   183

TABLE 163            GCC COUNTRIES: OTHER PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               184

TABLE 164            PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                186

TABLE 165            PEPTIDE SYNTHESIS SERVICE MARKET, BY REGION, 2022–2029 (USD MILLION)          187

TABLE 166            NORTH AMERICA: PEPTIDE SYNTHESIS SERVICE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               187

TABLE 167            EUROPE: PEPTIDE SYNTHESIS SERVICE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               188

TABLE 168            ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               188

TABLE 169            LATIN AMERICA: PEPTIDE SYNTHESIS SERVICE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               189

TABLE 170            MIDDLE EAST: PEPTIDE SYNTHESIS SERVICE MARKET,

BY REGION, 2022–2029 (USD MILLION)   189

TABLE 171            GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               189

TABLE 172            PEPTIDE PURIFICATION SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   190

TABLE 173            NORTH AMERICA: PEPTIDE PURIFICATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               191

TABLE 174            EUROPE: PEPTIDE PURIFICATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               191

TABLE 175            ASIA PACIFIC: PEPTIDE PURIFICATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               192

TABLE 176            LATIN AMERICA: PEPTIDE PURIFICATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               192

TABLE 177            MIDDLE EAST: PEPTIDE PURIFICATION SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   192

TABLE 178            GCC COUNTRIES: PEPTIDE PURIFICATION SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               193

TABLE 179            PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   193

TABLE 180            NORTH AMERICA: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               194

TABLE 181            EUROPE: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               194

TABLE 182            ASIA PACIFIC: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               195

TABLE 183            LATIN AMERICA: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               195

TABLE 184            MIDDLE EAST: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   195

TABLE 185            GCC COUNTRIES: PEPTIDE LIBRARY SYNTHESIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               196

TABLE 186            PEPTIDE ANALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          197

TABLE 187            NORTH AMERICA: PEPTIDE ANALYSIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               197

TABLE 188          EUROPE: PEPTIDE ANALYSIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               197

TABLE 189            ASIA PACIFIC: PEPTIDE ANALYSIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               198

TABLE 190            LATIN AMERICA: PEPTIDE ANALYSIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               198

TABLE 191            MIDDLE EAST: PEPTIDE ANALYSIS SERVICES MARKET,

BY REGION, 2022–2029 (USD MILLION)   199

TABLE 192            GCC COUNTRIES: PEPTIDE ANALYSIS SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               199

TABLE 193            PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION)            201

TABLE 194            PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         201

TABLE 195            PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY REGION, 2022–2029 (USD MILLION)   202

TABLE 196            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               202

TABLE 197            EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               203

TABLE 198            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               203

TABLE 199            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               204

TABLE 200            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY REGION, 2022–2029 (USD MILLION)   204

TABLE 201            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               204

TABLE 202            SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION,

2022–2029 (USD MILLION)            205

TABLE 203            NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               206

TABLE 204            EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               206

TABLE 205            ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               207

TABLE 206            LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               207

TABLE 207            MIDDLE EAST: SOLID-PHASE PEPTIDE SYNTHESIS MARKET,

BY REGION, 2022–2029 (USD MILLION)   207

TABLE 208            GCC COUNTRIES: SOLID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               208

TABLE 209            LIQUID-PHASE PEPTIDE SYNTHESIS MARKET,

BY REGION, 2022–2029 (USD MILLION)   209

TABLE 210            NORTH AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               209

TABLE 211            EUROPE: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               209

TABLE 212            ASIA PACIFIC: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               210

TABLE 213            LATIN AMERICA: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               210

TABLE 214            MIDDLE EAST: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET,

BY REGION, 2022–2029 (USD MILLION)   210

TABLE 215            GCC COUNTRIES: LIQUID-PHASE PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               211

TABLE 216            PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS,

BY REGION, 2022–2029 (USD MILLION)   212

TABLE 217            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION)            212

TABLE 218            EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               213

TABLE 219            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               213

TABLE 220            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 214

TABLE 221            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS,

BY REGION, 2022–2029 (USD MILLION)   214

TABLE 222            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER CHEMICAL METHODS, BY COUNTRY, 2022–2029 (USD MILLION) 214

TABLE 223            PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         215

TABLE 224            PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY REGION, 2022–2029 (USD MILLION)   215

TABLE 225            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               216

TABLE 226            EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               216

TABLE 227            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               217

TABLE 228            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               217

TABLE 229            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY REGION, 2022–2029 (USD MILLION)   217

TABLE 230            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY COUNTRY, 2022–2029 (USD MILLION)               218

TABLE 231            PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY,

BY REGION, 2022–2029 (USD MILLION)   219

TABLE 232            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)     219

TABLE 233            EUROPE: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY,

BY COUNTRY, 2022–2029 (USD MILLION)               220

TABLE 234            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)       220

TABLE 235            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)       221

TABLE 236            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION) 221

TABLE 237            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)       221

TABLE 238            PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS,

BY REGION, 2022–2029 (USD MILLION)   222

TABLE 239            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               222

TABLE 240            EUROPE: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               223

TABLE 241            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               223

TABLE 242            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               224

TABLE 243            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS,

BY REGION, 2022–2029 (USD MILLION)   224

TABLE 244            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR ENZYMATIC SYNTHESIS,

BY COUNTRY, 2022–2029 (USD MILLION)               224

TABLE 245          PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)            226

TABLE 246            PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   227

TABLE 247            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            227

TABLE 248            EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               228

TABLE 249            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               228

TABLE 250            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 229

TABLE 251            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   229

TABLE 252            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 229

TABLE 253            PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          230

TABLE 254            PEPTIDE SYNTHESIS MARKET FOR CANCER, BY REGION,

2022–2029 (USD MILLION)            231

TABLE 255            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               231

TABLE 256            EUROPE: PEPTIDE SYNTHESIS MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               231

TABLE 257            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               232

TABLE 258            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               232

TABLE 259            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CANCER,

BY REGION, 2022–2029 (USD MILLION)   232

TABLE 260            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CANCER,

BY COUNTRY, 2022–2029 (USD MILLION)               233

TABLE 261            PEPTIDE SYNTHESIS MARKET FOR DIABETES,

BY REGION, 2022–2029 (USD MILLION)   234

TABLE 262            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES,

BY COUNTRY, 2022–2029 (USD MILLION)               234

TABLE 263            EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIABETES,

BY COUNTRY, 2022–2029 (USD MILLION)               234

TABLE 264            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIABETES,

BY COUNTRY, 2022–2029 (USD MILLION)               235

TABLE 265            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIABETES,

BY COUNTRY, 2022–2029 (USD MILLION)               235

TABLE 266            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIABETES,

BY REGION, 2022–2029 (USD MILLION)   235

TABLE 267            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIABETES,

BY COUNTRY, 2022–2029 (USD MILLION)               236

TABLE 268            PEPTIDE SYNTHESIS MARKET FOR OBESITY,

BY REGION, 2022–2029 (USD MILLION)   237

TABLE 269            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY,

BY COUNTRY, 2022–2029 (USD MILLION)               237

TABLE 270            EUROPE: PEPTIDE SYNTHESIS MARKET FOR OBESITY,

BY COUNTRY, 2022–2029 (USD MILLION)               237

TABLE 271            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OBESITY,

BY COUNTRY, 2022–2029 (USD MILLION)               238

TABLE 272            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OBESITY,

BY COUNTRY, 2022–2029 (USD MILLION)               238

TABLE 273            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OBESITY,

BY REGION, 2022–2029 (USD MILLION)   238

TABLE 274            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OBESITY,

BY COUNTRY, 2022–2029 (USD MILLION)               239

TABLE 275            PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES,

BY REGION, 2022–2029 (USD MILLION)   240

TABLE 276            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               240

TABLE 277            EUROPE: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               241

TABLE 278            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               241

TABLE 279            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               242

TABLE 280            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES,

BY REGION, 2022–2029 (USD MILLION)   242

TABLE 281            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR AUTOIMMUNE DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               242

TABLE 282            PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES,

BY REGION, 2022–2029 (USD MILLION)   243

TABLE 283            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               244

TABLE 284            EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               244

TABLE 285            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               245

TABLE 286            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               245

TABLE 287            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES,

BY REGION, 2022–2029 (USD MILLION)   245

TABLE 288            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER DISEASES,

BY COUNTRY, 2022–2029 (USD MILLION)               246

TABLE 289            PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            246

TABLE 290            PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES,

BY REGION, 2022–2029 (USD MILLION)   247

TABLE 291            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)       247

TABLE 292            EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES,

BY COUNTRY, 2022–2029 (USD MILLION)               248

TABLE 293            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES,

BY COUNTRY, 2022–2029 (USD MILLION)               248

TABLE 294            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES,

BY COUNTRY, 2022–2029 (USD MILLION)               249

TABLE 295            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES,

BY REGION, 2022–2029 (USD MILLION)   249

TABLE 296            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-BASED VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)            249

TABLE 297            PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES,

BY REGION, 2022–2029 (USD MILLION)   250

TABLE 298            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION)            251

TABLE 299            EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES,

BY COUNTRY, 2022–2029 (USD MILLION)               251

TABLE 300            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES,

BY COUNTRY, 2022–2029 (USD MILLION)               252

TABLE 301            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 252

TABLE 302            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES,

BY REGION, 2022–2029 (USD MILLION)   252

TABLE 303            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE-DRUG CONJUGATES, BY COUNTRY, 2022–2029 (USD MILLION) 253

TABLE 304            PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS,

BY REGION, 2022–2029 (USD MILLION)   254

TABLE 305            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS,

BY COUNTRY, 2022–2029 (USD MILLION)               254

TABLE 306            EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS,

BY COUNTRY, 2022–2029 (USD MILLION)               255

TABLE 307            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS,

BY COUNTRY, 2022–2029 (USD MILLION)               255

TABLE 308            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS,

BY COUNTRY, 2022–2029 (USD MILLION)               256

TABLE 309            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS,

BY REGION, 2022–2029 (USD MILLION)   256

TABLE 310            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE INHIBITORS,

BY COUNTRY, 2022–2029 (USD MILLION)               256

TABLE 311            PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES,

BY REGION, 2022–2029 (USD MILLION)   257

TABLE 312            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES,

BY COUNTRY, 2022–2029 (USD MILLION)               258

TABLE 313            EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES,

BY COUNTRY, 2022–2029 (USD MILLION)               258

TABLE 314            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES,

BY COUNTRY, 2022–2029 (USD MILLION)               259

TABLE 315            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES,

BY COUNTRY, 2022–2029 (USD MILLION)               259

TABLE 316            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES,

BY REGION, 2022–2029 (USD MILLION)   259

TABLE 317            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR OTHER MOLECULES,

BY COUNTRY, 2022–2029 (USD MILLION)               260

TABLE 318            PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   261

TABLE 319            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)       261

TABLE 320            EUROPE: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               262

TABLE 321            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               262

TABLE 322            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)               263

TABLE 323            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS,

BY REGION, 2022–2029 (USD MILLION)   263

TABLE 324            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 263

TABLE 325            PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            264

TABLE 326            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY &

DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            265

TABLE 327            EUROPE: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            265

TABLE 328            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY &

DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            266

TABLE 329            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY &

DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            266

TABLE 330            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY &

DEVELOPMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)            266

TABLE 331            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR DISCOVERY &

DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)            267

TABLE 332            PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            269

TABLE 333            PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)          270

TABLE 334            NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES,

BY COUNTRY, 2022–2029 (USD MILLION)               270

TABLE 335            EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   271

TABLE 336            ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   271

TABLE 337            LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 272

TABLE 338            MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)        272

TABLE 339            GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 272

TABLE 340            PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS,

BY REGION, 2022–2029 (USD MILLION)   273

TABLE 341            NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS, BY COUNTRY, 2022–2029 (USD MILLION)       274

TABLE 342            EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               274

TABLE 343            ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               275

TABLE 344            LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               275

TABLE 345            MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS,

BY REGION, 2022–2029 (USD MILLION)   275

TABLE 346            GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               276

TABLE 347            PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC &

RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)                 277

TABLE 348            NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               277

TABLE 349            EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC &

RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)            278

TABLE 350            ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     278

TABLE 351            LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               279

TABLE 352            MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)            279

TABLE 353            GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               279

TABLE 354            PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES,

BY REGION, 2022–2029 (USD MILLION)   280

TABLE 355            NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     281

TABLE 356            EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)            281

TABLE 357            ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)            282

TABLE 358            LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     282

TABLE 359            MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION)       282

TABLE 360            GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     283

TABLE 361            PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION) 284

TABLE 362            NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)               284

TABLE 363            EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS &

DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)            285

TABLE 364            ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)     285

TABLE 365            LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)               286

TABLE 366            MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION)            286

TABLE 367            GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)               286

TABLE 368            PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            288

TABLE 369            PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)          289

TABLE 370            NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 289

TABLE 371            EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   290

TABLE 372            ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   290

TABLE 373            LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)   291

TABLE 374            MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2022–2029 (USD MILLION)        291

TABLE 375            GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 291

TABLE 376            PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES,

BY REGION, 2022–2029 (USD MILLION)   292

TABLE 377            NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     293

TABLE 378            EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)            293

TABLE 379            ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)            294

TABLE 380            LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)            294

TABLE 381            MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022–2029 (USD MILLION)       294

TABLE 382            GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)     295

TABLE 383            PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION) 296

TABLE 384            NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)               296

TABLE 385            EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)     297

TABLE 386            ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)     297

TABLE 387            LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)     298

TABLE 388            MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2022–2029 (USD MILLION)            298

TABLE 389            GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)               298

TABLE 390            PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 299

TABLE 391            NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               300

TABLE 392            EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC &

RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)            300

TABLE 393            ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     301

TABLE 394            LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)     301

TABLE 395            MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)            301

TABLE 396            GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)               302

TABLE 397            PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS,

BY REGION, 2022–2029 (USD MILLION)   303

TABLE 398            NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               303

TABLE 399            EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               304

TABLE 400            ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               304

TABLE 401            LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               305

TABLE 402            MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS,

BY REGION, 2022–2029 (USD MILLION)   305

TABLE 403            GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET FOR CROS & CMOS,

BY COUNTRY, 2022–2029 (USD MILLION)               305

TABLE 404            PEPTIDE SYNTHESIS MARKET, BY REGION, 2022–2029 (USD MILLION)            307

TABLE 405            KEY MACROECONOMIC INDICATORS FOR NORTH AMERICA             308

TABLE 406            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING,

2022–2029 (USD MILLION)            309

TABLE 407            NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         310

TABLE 408            NORTH AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         310

TABLE 409            NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         310

TABLE 410            NORTH AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         311

TABLE 411            NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         311

TABLE 412            NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         311

TABLE 413            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          312

TABLE 414            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         312

TABLE 415            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         312

TABLE 416            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       313

TABLE 417            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)            313

TABLE 418            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)            313

TABLE 419            NORTH AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               314

TABLE 420            NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               314

TABLE 421          US: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)            315

TABLE 422            US: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         315

TABLE 423            US: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         316

TABLE 424            US: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         316

TABLE 425            US: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         316

TABLE 426            US: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)            317

TABLE 427            US: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                317

TABLE 428            US: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 317

TABLE 429            US: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         318

TABLE 430            US: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         318

TABLE 431            US: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              318

TABLE 432            US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          319

TABLE 433            US: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            319

TABLE 434            US: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            320

TABLE 435            US: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            320

TABLE 436            CANADA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     321

TABLE 437            CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         321

TABLE 438            CANADA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         322

TABLE 439            CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         322

TABLE 440            CANADA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         322

TABLE 441            CANADA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)                323

TABLE 442            CANADA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         323

TABLE 443            CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            323

TABLE 444            CANADA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         324

TABLE 445            CANADA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         324

TABLE 446            CANADA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            324

TABLE 447            CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          325

TABLE 448            CANADA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            325

TABLE 449            CANADA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               326

TABLE 450            CANADA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               326

TABLE 451            KEY MACROECONOMIC INDICATORS FOR EUROPE               327

TABLE 452            EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     328

TABLE 453            EUROPE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     328

TABLE 454            EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         328

TABLE 455            EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         329

TABLE 456            EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         329

TABLE 457            EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         329

TABLE 458            EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)                330

TABLE 459            EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         330

TABLE 460            EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            330

TABLE 461            EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         331

TABLE 462            EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         331

TABLE 463            EUROPE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            331

TABLE 464            EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          332

TABLE 465            EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            332

TABLE 466            EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               333

TABLE 467            EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               333

TABLE 468            GERMANY: PEPTIDE SYNTHESIS MARKET, BY OFFERING,

2022–2029 (USD MILLION)            334

TABLE 469            GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         335

TABLE 470            GERMANY: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         335

TABLE 471            GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         335

TABLE 472            GERMANY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         336

TABLE 473            GERMANY: PEPTIDE SYNTHESIS SYNTHESIZERS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         336

TABLE 474            GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         336

TABLE 475            GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            337

TABLE 476            GERMANY: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         337

TABLE 477            GERMANY: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         337

TABLE 478            GERMANY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            338

TABLE 479            GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          338

TABLE 480            GERMANY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            338

TABLE 481            GERMANY: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               339

TABLE 482            GERMANY: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               339

TABLE 483            UK: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     340

TABLE 484            UK: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         340

TABLE 485            UK: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         341

TABLE 486            UK: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         341

TABLE 487            UK: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         341

TABLE 488            UK: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)            342

TABLE 489            UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)                342

TABLE 490            UK: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 342

TABLE 491            UK: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         343

TABLE 492            UK: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         343

TABLE 493            UK: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              343

TABLE 494            UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)        344

TABLE 495            UK: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            344

TABLE 496            UK: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            345

TABLE 497            UK: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            345

TABLE 498            FRANCE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     346

TABLE 499            FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         346

TABLE 500            FRANCE: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         347

TABLE 501            FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         347

TABLE 502            FRANCE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         347

TABLE 503            FRANCE: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)                348

TABLE 504            FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         348

TABLE 505            FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            348

TABLE 506            FRANCE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         349

TABLE 507            FRANCE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         349

TABLE 508            FRANCE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            349

TABLE 509            FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          350

TABLE 510            FRANCE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            350

TABLE 511            FRANCE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               351

TABLE 512            FRANCE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               351

TABLE 513            ITALY: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     352

TABLE 514            ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         352

TABLE 515            ITALY: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         353

TABLE 516            ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         353

TABLE 517            ITALY: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         353

TABLE 518            ITALY: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)                354

TABLE 519            ITALY: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         354

TABLE 520            ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 354

TABLE 521            ITALY: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         355

TABLE 522            ITALY: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         355

TABLE 523            ITALY: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              355

TABLE 524            ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          356

TABLE 525            ITALY: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            356

TABLE 526            ITALY: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               357

TABLE 527            ITALY: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               357

TABLE 528            SPAIN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     358

TABLE 529            SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         358

TABLE 530            SPAIN: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         358

TABLE 531            SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         359

TABLE 532            SPAIN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         359

TABLE 533            SPAIN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)                359

TABLE 534            SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         360

TABLE 535            SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 360

TABLE 536            SPAIN: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         360

TABLE 537            SPAIN: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         361

TABLE 538            SPAIN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            361

TABLE 539            SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          361

TABLE 540            SPAIN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            362

TABLE 541            SPAIN: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               362

TABLE 542            SPAIN: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               363

TABLE 543          REST OF EUROPE: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               364

TABLE 544            REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         364

TABLE 545            REST OF EUROPE: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         364

TABLE 546            REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         365

TABLE 547            REST OF EUROPE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         365

TABLE 548            REST OF EUROPE: PEPTIDE SYNTHESIZERS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         365

TABLE 549            REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         366

TABLE 550          REST OF EUROPE: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          366

TABLE 551            REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         366

TABLE 552            REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         367

TABLE 553          REST OF EUROPE: PEPTIDE SYNTHESIS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       367

TABLE 554            REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 367

TABLE 555            REST OF EUROPE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 368

TABLE 556            REST OF EUROPE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               368

TABLE 557            REST OF EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               369

TABLE 558            KEY MACROECONOMIC INDICATORS FOR ASIA PACIFIC                370

TABLE 559            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)            372

TABLE 560            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING,

2022–2029 (USD MILLION)            372

TABLE 561            ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         372

TABLE 562            ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         373

TABLE 563            ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         373

TABLE 564            ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         373

TABLE 565          ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         374

TABLE 566            ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         374

TABLE 567            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          374

TABLE 568            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         375

TABLE 569            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         375

TABLE 570            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            375

TABLE 571            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          376

TABLE 572            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            376

TABLE 573            ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               377

TABLE 574            ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               377

TABLE 575            CHINA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     378

TABLE 576            CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         378

TABLE 577            CHINA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         379

TABLE 578            CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         379

TABLE 579            CHINA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         379

TABLE 580            CHINA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)                380

TABLE 581          CHINA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         380

TABLE 582            CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 380

TABLE 583            CHINA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         381

TABLE 584            CHINA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         381

TABLE 585            CHINA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            381

TABLE 586            CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          382

TABLE 587            CHINA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            382

TABLE 588            CHINA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               383

TABLE 589          CHINA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               383

TABLE 590            JAPAN: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     384

TABLE 591            JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         384

TABLE 592            JAPAN: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         385

TABLE 593            JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         385

TABLE 594            JAPAN: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         385

TABLE 595            JAPAN: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)                386

TABLE 596            JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         386

TABLE 597            JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 386

TABLE 598            JAPAN: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         387

TABLE 599            JAPAN: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         387

TABLE 600            JAPAN: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            387

TABLE 601            JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          388

TABLE 602            JAPAN: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            388

TABLE 603            JAPAN: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               389

TABLE 604            JAPAN: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               389

TABLE 605            INDIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     390

TABLE 606            INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         390

TABLE 607            INDIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         391

TABLE 608            INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         391

TABLE 609            INDIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         391

TABLE 610            INDIA: PEPTIDE SYNTHESIZERS MARKET, BY TYPE, 2022–2029 (USD MILLION)                392

TABLE 611            INDIA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         392

TABLE 612            INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 392

TABLE 613            INDIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         393

TABLE 614            INDIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         393

TABLE 615            INDIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              393

TABLE 616            INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          394

TABLE 617            INDIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            394

TABLE 618            INDIA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               395

TABLE 619            INDIA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               395

TABLE 620            SOUTH KOREA: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               396

TABLE 621            SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         396

TABLE 622            SOUTH KOREA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         397

TABLE 623            SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         397

TABLE 624            SOUTH KOREA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         397

TABLE 625            SOUTH KOREA: PEPTIDE SYNTHESIZERS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         398

TABLE 626            SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         398

TABLE 627            SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            398

TABLE 628            SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         399

TABLE 629            SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         399

TABLE 630            SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            399

TABLE 631            SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 400

TABLE 632            SOUTH KOREA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 400

TABLE 633            SOUTH KOREA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               401

TABLE 634            SOUTH KOREA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               401

TABLE 635            AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY OFFERING,

2022–2029 (USD MILLION)            402

TABLE 636            AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         402

TABLE 637            AUSTRALIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         403

TABLE 638            AUSTRALIA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         403

TABLE 639            AUSTRALIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         403

TABLE 640            AUSTRALIA: PEPTIDE SYNTHESIZERS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         404

TABLE 641            AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         404

TABLE 642            AUSTRALIA: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          404

TABLE 643            AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         405

TABLE 644            AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         405

TABLE 645            AUSTRALIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            405

TABLE 646            AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          406

TABLE 647            AUSTRALIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            406

TABLE 648            AUSTRALIA: PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER,

2022–2029 (USD MILLION)            407

TABLE 649            AUSTRALIA: PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER,

2022–2029 (USD MILLION)            407

TABLE 650            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY OFFERING,

2022–2029 (USD MILLION)            408

TABLE 651            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         408

TABLE 652            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         409

TABLE 653            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         409

TABLE 654            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         409

TABLE 655            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         410

TABLE 656            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         410

TABLE 657            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          410

TABLE 658            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)            411

TABLE 659            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)            411

TABLE 660            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       411

TABLE 661            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)            412

TABLE 662            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTICS,

BY MOLECULE, 2022–2029 (USD MILLION)            412

TABLE 663            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               413

TABLE 664            REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               413

TABLE 665            KEY MACROECONOMIC INDICATORS FOR LATIN AMERICA                414

TABLE 666            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               415

TABLE 667            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               415

TABLE 668            LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         415

TABLE 669            LATIN AMERICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         416

TABLE 670            LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         416

TABLE 671            LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         416

TABLE 672            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS,

BY TYPE, 2022–2029 (USD MILLION)         417

TABLE 673            LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         417

TABLE 674            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          417

TABLE 675            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         418

TABLE 676            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         418

TABLE 677            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            418

TABLE 678            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 419

TABLE 679            LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 419

TABLE 680            LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               420

TABLE 681            LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               420

TABLE 682            BRAZIL: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     421

TABLE 683            BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         421

TABLE 684            BRAZIL: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         422

TABLE 685            BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         422

TABLE 686            BRAZIL: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         422

TABLE 687            BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)            423

TABLE 688            BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         423

TABLE 689            BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            423

TABLE 690            BRAZIL: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         424

TABLE 691            BRAZIL: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         424

TABLE 692            BRAZIL: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            424

TABLE 693            BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          425

TABLE 694            BRAZIL: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            425

TABLE 695            BRAZIL: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               426

TABLE 696            BRAZIL: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               426

TABLE 697            MEXICO: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     427

TABLE 698            MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         427

TABLE 699            MEXICO: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         428

TABLE 700            MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         428

TABLE 701            MEXICO: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         428

TABLE 702            MEXICO: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)                429

TABLE 703            MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         429

TABLE 704            MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            429

TABLE 705            MEXICO: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         430

TABLE 706            MEXICO: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         430

TABLE 707            MEXICO: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            430

TABLE 708            MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          431

TABLE 709            MEXICO: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            431

TABLE 710            MEXICO: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               432

TABLE 711            MEXICO: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               432

TABLE 712            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               433

TABLE 713            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         433

TABLE 714            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CONSUMABLES,

BY TYPE, 2022–2029 (USD MILLION)         433

TABLE 715            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         434

TABLE 716            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         434

TABLE 717            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         434

TABLE 718            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         435

TABLE 719            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          435

TABLE 720            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)            435

TABLE 721            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)            436

TABLE 722            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       436

TABLE 723            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)            436

TABLE 724            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)            437

TABLE 725            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               437

TABLE 726            REST OF LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               438

TABLE 727            KEY MACROECONOMIC INDICATORS FOR MIDDLE EAST   439

TABLE 728            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET,

BY REGION, 2022–2029 (USD MILLION)   439

TABLE 729            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               439

TABLE 730            MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         440

TABLE 731            MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         440

TABLE 732            MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         440

TABLE 733            MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         441

TABLE 734            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)         441

TABLE 735            MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         441

TABLE 736            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            442

TABLE 737            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         442

TABLE 738            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         442

TABLE 739            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            443

TABLE 740            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          443

TABLE 741            MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            443

TABLE 742            MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               444

TABLE 743            MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               444

TABLE 744          GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)               445

TABLE 745          GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               445

TABLE 746            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR PRODUCTS,

BY TYPE, 2022–2029 (USD MILLION)         446

TABLE 747            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CONSUMABLES,

BY TYPE, 2022–2029 (USD MILLION)         446

TABLE 748            GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         446

TABLE 749            GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         447

TABLE 750          GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         447

TABLE 751            GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         447

TABLE 752          GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          448

TABLE 753            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         448

TABLE 754            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         448

TABLE 755          GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            449

TABLE 756            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION) 449

TABLE 757            GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION) 449

TABLE 758            GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               450

TABLE 759            GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               450

TABLE 760            SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               451

TABLE 761            SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         451

TABLE 762            SAUDI ARABIA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         452

TABLE 763            SAUDI ARABIA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         452

TABLE 764            SAUDI ARABIA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         452

TABLE 765            SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         453

TABLE 766            SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         453

TABLE 767            SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          453

TABLE 768            SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHOD,

BY TYPE, 2022–2029 (USD MILLION)         454

TABLE 769            SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         454

TABLE 770            SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            454

TABLE 771            SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          455

TABLE 772            SAUDI ARABIA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            455

TABLE 773            SAUDI ARABIA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               456

TABLE 774            SAUDI ARABIA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               456

TABLE 775            UAE: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     457

TABLE 776            UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         457

TABLE 777            UAE: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         458

TABLE 778            UAE: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         458

TABLE 779            UAE: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         458

TABLE 780            UAE: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)            459

TABLE 781            UAE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         459

TABLE 782            UAE: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 459

TABLE 783            UAE: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         460

TABLE 784            UAE: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         460

TABLE 785            UAE: PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)              460

TABLE 786            UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          461

TABLE 787            UAE: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            461

TABLE 788            UAE: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               462

TABLE 789            UAE: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               462

TABLE 790            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               463

TABLE 791            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         463

TABLE 792            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         464

TABLE 793            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         464

TABLE 794            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         464

TABLE 795            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         465

TABLE 796            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         465

TABLE 797            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          465

TABLE 798            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET

FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)                 466

TABLE 799            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET

FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)            466

TABLE 800            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       466

TABLE 801            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)            467

TABLE 802            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)            467

TABLE 803            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               468

TABLE 804            REST OF GCC COUNTRIES: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               468

TABLE 805            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET,

BY OFFERING, 2022–2029 (USD MILLION)               469

TABLE 806            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         469

TABLE 807            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         470

TABLE 808            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         470

TABLE 809            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         470

TABLE 810            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         471

TABLE 811            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         471

TABLE 812            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET,

BY TECHNIQUE, 2022–2029 (USD MILLION)          471

TABLE 813            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)            472

TABLE 814            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS, BY TYPE, 2022–2029 (USD MILLION)            472

TABLE 815            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)       472

TABLE 816            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY INDICATION, 2022–2029 (USD MILLION)            473

TABLE 817            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY MOLECULE, 2022–2029 (USD MILLION)            473

TABLE 818            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               474

TABLE 819            REST OF MIDDLE EAST: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               474

TABLE 820            KEY MACROECONOMIC INDICATORS FOR AFRICA 476

TABLE 821            AFRICA: PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2022–2029 (USD MILLION)     476

TABLE 822            AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         476

TABLE 823            AFRICA: PEPTIDE SYNTHESIS CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         477

TABLE 824            AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         477

TABLE 825            AFRICA: PEPTIDE SYNTHESIS INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)         477

TABLE 826          AFRICA: PEPTIDE SYNTHESIS MARKET, BY TYPE, 2022–2029 (USD MILLION)            478

TABLE 827            AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY TYPE, 2022–2029 (USD MILLION)         478

TABLE 828            AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE,

2022–2029 (USD MILLION)            478

TABLE 829            AFRICA: PEPTIDE SYNTHESIS MARKET FOR CHEMICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         479

TABLE 830            AFRICA: PEPTIDE SYNTHESIS MARKET FOR BIOLOGICAL METHODS,

BY TYPE, 2022–2029 (USD MILLION)         479

TABLE 831            AFRICA: PEPTIDE SYNTHESIS MARKET, BY APPLICATION,

2022–2029 (USD MILLION)            479

TABLE 832            AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY INDICATION, 2022–2029 (USD MILLION)          480

TABLE 833            AFRICA: PEPTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,

BY MOLECULE, 2022–2029 (USD MILLION)            480

TABLE 834            AFRICA: PEPTIDE SYNTHESIS PRODUCTS MARKET,

BY END USER, 2022–2029 (USD MILLION)               481

TABLE 835            AFRICA: PEPTIDE SYNTHESIS SERVICES MARKET,

BY END USER, 2022–2029 (USD MILLION)               481

TABLE 836            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2021–2025         483

TABLE 837            PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION 486

TABLE 838            PEPTIDE SYNTHESIS MARKET: REGION FOOTPRINT       492

TABLE 839            PEPTIDE SYNTHESIS MARKET: OFFERING FOOTPRINT       493

TABLE 840            PEPTIDE SYNTHESIS MARKET: TECHNIQUE FOOTPRINT       494

TABLE 841            PEPTIDE SYNTHESIS MARKET: APPLICATION FOOTPRINT       495

TABLE 842            PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY STARTUPS/SMES              498

TABLE 843            PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES   499

TABLE 844            PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES,

JANUARY 2021–DECEMBER 2024 500

TABLE 845            PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2021–DECEMBER 2024     501

TABLE 846            PEPTIDE SYNTHESIS MARKET: EXPANSIONS, JANUARY 2021–DECEMBER 2024 502

TABLE 847            THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW          503

TABLE 848            THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED               505

TABLE 849            THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024      506

TABLE 850            MERCK KGAA: COMPANY OVERVIEW     507

TABLE 851            MERCK KGAA: PRODUCTS/SERVICES OFFERED                 508

TABLE 852            AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW          512

TABLE 853            AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED               513

TABLE 854            GENSCRIPT: COMPANY OVERVIEW         515

TABLE 855            GENSCRIPT: PRODUCTS/SERVICES OFFERED                 516

TABLE 856            GENSCRIPT: EXPANSIONS, JANUARY 2021−DECEMBER 2024   517

TABLE 857            KANEKA CORPORATION: COMPANY OVERVIEW                 519

TABLE 858            KANEKA CORPORATION: PRODUCTS/SERVICES OFFERED             520

TABLE 859            KANEKA CORPORATION: EXPANSIONS, JANUARY 2021−DECEMBER 2024               521

TABLE 860            BACHEM: COMPANY OVERVIEW               522

TABLE 861            BACHEM: PRODUCTS/SERVICES OFFERED                 523

TABLE 862            BACHEM: DEALS, JANUARY 2021−DECEMBER 2024        524

TABLE 863            SYNGENE INTERNATIONAL LIMITED: COMPANY OVERVIEW   525

TABLE 864            SYNGENE INTERNATIONAL LIMITED: PRODUCTS/SERVICES OFFERED               526

TABLE 865            MESA LABS, INC.: COMPANY OVERVIEW                 527

TABLE 866            MESA LABS, INC.: PRODUCTS/SERVICES OFFERED             528

TABLE 867            MESA LABS, INC.: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024               529

TABLE 868            MESA LABS, INC.: DEALS, JANUARY 2021−DECEMBER 2024   529

TABLE 869            BIOTAGE: COMPANY OVERVIEW              530

TABLE 870            BIOTAGE: PRODUCTS/SERVICES OFFERED                 532

TABLE 871            CEM CORPORATION: COMPANY OVERVIEW                 533

TABLE 872            CEM CORPORATION: PRODUCTS/SERVICES OFFERED             533

TABLE 873            CEM CORPORATION: PRODUCT LAUNCHES, JANUARY 2021−DECEMBER 2024               534

TABLE 874            CEM CORPORATION: DEALS, JANUARY 2021−DECEMBER 2024   534

TABLE 875            DALTON PHARMA SERVICES: COMPANY OVERVIEW          535

TABLE 876            DALTON PHARMA SERVICES: PRODUCTS/SERVICES OFFERED               535

TABLE 877            BIO-SYNTHESIS INC.: COMPANY OVERVIEW                 536

TABLE 878            BIO-SYNTHESIS INC.: PRODUCTS/SERVICES OFFERED             537

TABLE 879            CSBIO: COMPANY OVERVIEW    538

TABLE 880            CSBIO: PRODUCTS/SERVICES OFFERED                 538

TABLE 881            PROTEOGENIX: COMPANY OVERVIEW  539

TABLE 882            PROTEOGENIX: PRODUCTS/SERVICES OFFERED             539

TABLE 883            INNOVAGEN AB: COMPANY OVERVIEW 540

TABLE 884            INNOVAGEN AB: PRODUCTS/SERVICES OFFERED             540

TABLE 885            BIOSYNTH: COMPANY OVERVIEW           541

TABLE 886            BIOSYNTH: PRODUCTS/SERVICES OFFERED                 541

TABLE 887            BIOSYNTH: DEALS, JANUARY 2021−DECEMBER 2024        542

TABLE 888            AURIGENE PHARMACEUTICAL SERVICES LTD.: COMPANY OVERVIEW   543

TABLE 889            CORDENPHARMA: COMPANY OVERVIEW                 544

TABLE 890            JPT PEPTIDE TECHNOLOGIES: COMPANY OVERVIEW          545

TABLE 891            PUROLITE: COMPANY OVERVIEW            546

TABLE 892            BIOMATIK: COMPANY OVERVIEW            547

TABLE 893            CPC SCIENTIFIC INC.: COMPANY OVERVIEW                 548

TABLE 894            ADVANCED CHEMTECH, INC.: COMPANY OVERVIEW          549

TABLE 895            AMBIOPHARM INC.: COMPANY OVERVIEW                 550

TABLE 896            LUXEMBOURG BIO TECHNOLOGIES: COMPANY OVERVIEW          551

TABLE 897            AAPPTEC: COMPANY OVERVIEW              552

TABLE 898            ANYGEN: COMPANY OVERVIEW                553

TABLE 899            CHEMPEP: COMPANY OVERVIEW             554

TABLE 900            PROTEOGENIX: COMPANY OVERVIEW  555

LIST OF FIGURES

FIGURE 1              PEPTIDE SYNTHESIS MARKET SEGMENTATION                 55

FIGURE 2              PEPTIDE SYNTHESIS MARKET: RESEARCH DESIGN                59

FIGURE 3              PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS  61

FIGURE 4              PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023      62

FIGURE 5              GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE

ANALYSIS-BASED ESTIMATION), 2023     63

FIGURE 6              ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.:

REVENUE SHARE ANALYSIS, 2023               63

FIGURE 7              MARKET SIZE VALIDATION FROM PRIMARY SOURCES             65

FIGURE 8              MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH                65

FIGURE 9              PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS   67

FIGURE 10            DATA TRIANGULATION METHODOLOGY                 69

FIGURE 11            PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)      72

FIGURE 12            PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)         73

FIGURE 13            PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION)      73

FIGURE 14            PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)         74

FIGURE 15           PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)      75

FIGURE 16            PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)      75

FIGURE 17            PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)      76

FIGURE 18            GEOGRAPHICAL SNAPSHOT OF PEPTIDE SYNTHESIS MARKET, 2024–2029  77

FIGURE 19            EXPANDING APPLICATIONS OF PEPTIDES IN DIAGNOSTICS, THERAPEUTICS,

AND VACCINES TO DRIVE MARKET         78

FIGURE 20            CONSUMABLES SEGMENT AND US LED NORTH AMERICAN MARKET IN 2023        79

FIGURE 21            PRODUCTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD       79

FIGURE 22            CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD         80

FIGURE 23            PEPTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          81

FIGURE 24            TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS   87

FIGURE 25            AVERAGE SELLING PRICE OF PEPTIDE SYNTHESIS PRODUCTS,

BY KEY PLAYER, 2024      89

FIGURE 26            AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS,

BY TYPE, 2022–2024          90

FIGURE 27            AVERAGE SELLING PRICE TREND OF PEPTIDE SYNTHESIS PRODUCTS,

BY REGION, 2024               92

FIGURE 28            PEPTIDE SYNTHESIS MARKET: SUPPLY CHAIN ANALYSIS            93

FIGURE 29            PEPTIDE SYNTHESIS MARKET: VALUE CHAIN ANALYSIS            95

FIGURE 30            PEPTIDE SYNTHESIS MARKET: ECOSYSTEM ANALYSIS            97

FIGURE 31            PEPTIDE SYNTHESIS MARKET: PATENT ANALYSIS, 2014−2024     103

FIGURE 32            PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS           114

FIGURE 33            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS   116

FIGURE 34            KEY BUYING CRITERIA FOR PEPTIDE SYNTHESIS PRODUCTS, BY END USER   117

FIGURE 35            NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT       309

FIGURE 36            ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT          371

FIGURE 37            REVENUE ANALYSIS OF KEY PLAYERS IN PEPTIDE

SYNTHESIS MARKET, 2019–2023  484

FIGURE 38            MARKET SHARE ANALYSIS OF KEY PLAYERS IN PEPTIDE SYNTHESIS

MARKET, 2023    485

FIGURE 39            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS, 2025 487

FIGURE 40            EV/EBITDA OF KEY VENDORS, 2025         487

FIGURE 41            PEPTIDE SYNTHESIS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     488

FIGURE 42            PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023       490

FIGURE 43            PEPTIDE SYNTHESIS MARKET: COMPANY FOOTPRINT       491

FIGURE 44            PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX

(STARTUPS/SMES), 2023                497

FIGURE 45            THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)             504

FIGURE 46            MERCK KGAA: COMPANY SNAPSHOT (2023)                 508

FIGURE 47            AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)             513

FIGURE 48            GENSCRIPT: COMPANY SNAPSHOT (2023)                 516

FIGURE 49            KANEKA CORPORATION: COMPANY SNAPSHOT (2023)    520

FIGURE 50            BACHEM: COMPANY SNAPSHOT (2023)  523

FIGURE 51            SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2023)      525

FIGURE 52            MESA LABS, INC.: COMPANY SNAPSHOT (2023)                 528

FIGURE 53            BIOTAGE: COMPANY SNAPSHOT (2023) 531

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧